Eris Lifesciences

Price chart

Previous close

₹1,252.70

Open

₹1,276.00

Day high

₹1,278.10

Day low

₹1,250.00

Listed on NSE since 29 June 2017.

Market value

₹17,524 Cr

P/E (trailing)

24.93

EPS (trailing)

₹50.66

Price to book

4.23

Dividend yield

1.15%

Return on equity

18.8%

Debt to equity

0.59

Profit margin

21.4%

Beta

-0.05

Volume today

49,639

Average volume

1.04 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Eris Lifesciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of Eris Lifesciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Eris Lifesciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, GLP-1, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram monitoring, continuous glucose monitoring system, sleep device, antenatal care, and early neuropathy screening solutions, as well as polycystic ovary syndrome screening, diagnosis, and management. The company offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Ahmedabad

Employees

2,758

Company website · Profile: Yahoo Finance

No headlines name Eris Lifesciences in the last day or two.

• Interim Dividend - Rs 7.21 Per Share

  Dividend · ex-date 29 May 2026

• Interim Dividend - Rs 7.35 Per Share

  Dividend · ex-date 13 February 2025

• Annual General Meeting

  Action · ex-date 17 September 2024

• Annual General Meeting

  Action · ex-date 15 September 2023

• Annual General Meeting

  Action · ex-date 23 August 2022

• Interim Dividend- Rs 7.35 Per Share

  Dividend · ex-date 11 August 2022 · record date 16 August 2022

• Annual General Meeting

  Action · ex-date 23 August 2021

• Interim Dividend - Rs 6.01 Per Share

  Dividend · ex-date 5 August 2021 · record date 6 August 2021

Source: NSE. Latest first, 8 of 15.